The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...

The vote offers a sigh of relief to doctors and public health experts worried about vaccine skepticism creeping into policymaking.

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...

In recent weeks, Health and Human Services Secretary Robert F. Kennedy Jr. has begun to dismantle decades of vaccine safety ...

The sound of rain may feel romantic to some, but for parents? It’s a seasonal alarm bell. Not just puddles and power cuts, an annual wave of infections that hit kids the hardest.

A newly approved shot could soon help protect babies from respiratory syncytial virus, the top cause of hospitalization in US infants.

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...

MPV tends to hit hardest in young children, older adults and people with weakened immune systems. A virologist explains.